Sorry! The page you requested could not be found
Our website is continually being revised and updated and the information you are trying to reach may no longer be available or it could also be located elsewhere on the website.
Visit the Home page
AstraZeneca Pty Ltd, Alma Road, North Ryde NSW 2113, Australia. ABN 54 009 682 311.
emla® is a registered trademark of AstraZeneca Pty Ltd.
References: 1. emla® Approved Product Information, March 2010 2. Data on File at AstraZeneca Pty Ltd. 3. Hamilton JG. Fam Pract 1995 Aug; 4(2): 169-175
Always read the label before using emla®. Use only as directed. See leaflet for further information.
Indications for emla®: Topical anaesthesia of the skin prior to vaccination. Active Ingredients: lignocaine 2.5% and prilocaine 2.5%.
All information displayed in this site is intended for Australian residents only and is not designed to replace the advice of your doctor or healthcare professional.